KARPAS 1718 Human Splenic Lymphoma cell line useful in oncology research, developed at the University of Cambridge.
Publications:
Ota et al (2004) Cancer Res. 64 (9), 3087-3095.
Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.
Enquiry for KARPAS 1718 Human Splenic Lymphoma cell line
Reagents Enquiry
To find out more about how this website collects your personal data see www.enterprise.cam.ac.uk/about-us/information-compliance/data-protection/core-privacy-notices/website-users-use-personal-information/